Pricing Log in Create free account

Contineum Therapeutics, Inc. (CTNM) vs Orchestra BioMed Holdings, Inc. (OBIO)

Contineum Therapeutics, Inc. and Orchestra BioMed Holdings, Inc. are both Biotechnology companies. Contineum Therapeutics, Inc. and Orchestra BioMed Holdings, Inc. are of similar size ($345.9M and $337.8M). Contineum Therapeutics, Inc. has the higher net margin (0.00% vs −186.3%) and the lower return on invested capital (−4,845.6% vs 0.00%). Across the 13 metrics below, Contineum Therapeutics, Inc. leads on 9 and Orchestra BioMed Holdings, Inc. on 4.

Valuation

Metric CTNM OBIO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 11.34 9.40
P/B 1.47 18.76 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 8.99 9.02
Earnings yield (18.76%) (17.85%) (32.88%)
Free cash flow yield (14.44%) (16.31%) (23.13%)

Profitability

Metric CTNM OBIO Biotechnology median
Gross margin — 99.51% 68.51%
Operating margin 0.00% (181.36%) 0.00%
Net margin 0.00% (186.30%) 0.00%
Free cash flow margin 0.00% (184.83%) 0.00%
Return on equity (29.80%) (607.32%) (51.96%)
Return on assets (28.34%) (75.16%) (46.06%)
Return on invested capital (4,845.62%) 0.00% 0.00%

Growth

Metric CTNM OBIO Biotechnology median
Revenue growth (TTM) — 986.14% 6.76%
EPS growth (last fiscal year) 0.46% 33.13% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CTNM OBIO Biotechnology median
Debt to equity 0.00 1.80 0.00
Current ratio 31.11 8.26 4.97
Net debt to EBITDA 3.88 1.80 1.01

Dividend

Metric CTNM OBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CTNM OBIO Biotechnology median
Market cap 345.93m 337.79m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack